<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction Schema extraction-schema-95 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extraction Schema Details for extraction-schema-95</h1>

        <div class="section">
            <h2>Extraction Schema (General Information)</h2>
            <div class="info-section">
                <p><strong>Schema ID:</strong> extraction-schema-95</p>
                <p><strong>Extraction Query:</strong> Extract any mentions of selective vulnerability or resistance of specific neuronal populations, cell types, layers, or regions within the visual cortex to amyloid-β (amyloid-beta) plaques and tau protein tangles in the context of dementia or Alzheimer's disease.</p>
            </div>
        </div>

        <div class="section">
            <h2>Extraction Schema (Details)</h2>
            <table>
                <thead>
                    <tr>
                        <th style="width: 20%;">Field Name</th>
                        <th style="width: 15%;">Type</th>
                        <th style="width: 65%;">Description</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>neuronal_population_type</strong></td>
                        <td>str</td>
                        <td>The specific type of neuronal population, cell type, cortical layer, or visual cortex region being studied (e.g., 'layer 5 pyramidal neurons', 'parvalbumin-positive interneurons', 'V1 primary visual cortex', 'MT/V5 motion area', etc.)</td>
                    </tr>
                    <tr>
                        <td><strong>vulnerability_status</strong></td>
                        <td>str</td>
                        <td>Is this neuronal population vulnerable, resistant, or intermediate to amyloid-β and/or tau pathology? Be specific about which pathology if only one is mentioned.</td>
                    </tr>
                    <tr>
                        <td><strong>amyloid_beta_measurement</strong></td>
                        <td>str</td>
                        <td>Quantitative or qualitative measurements of amyloid-β plaque burden, density, or accumulation in this neuronal population (include units and numerical values if available, null if no information)</td>
                    </tr>
                    <tr>
                        <td><strong>tau_measurement</strong></td>
                        <td>str</td>
                        <td>Quantitative or qualitative measurements of tau tangle burden, density, or accumulation in this neuronal population (include units and numerical values if available, null if no information)</td>
                    </tr>
                    <tr>
                        <td><strong>cellular_properties</strong></td>
                        <td>str</td>
                        <td>Specific cellular or molecular properties of this neuronal population that are mentioned in relation to vulnerability or resistance (e.g., metabolic rate, calcium buffering capacity, connectivity patterns, gene expression profiles, protein levels, etc.)</td>
                    </tr>
                    <tr>
                        <td><strong>proposed_mechanism</strong></td>
                        <td>str</td>
                        <td>The proposed mechanism or explanation for why this neuronal population is vulnerable or resistant to pathology. Be detailed and specific.</td>
                    </tr>
                    <tr>
                        <td><strong>comparative_population</strong></td>
                        <td>str</td>
                        <td>If the study compares this population to another population with different vulnerability, name the comparison population and briefly describe the key differences.</td>
                    </tr>
                    <tr>
                        <td><strong>species_and_model</strong></td>
                        <td>str</td>
                        <td>What species and experimental model was used? (e.g., 'human post-mortem tissue', 'APP/PS1 mouse model', '3xTg-AD mice', etc.)</td>
                    </tr>
                    <tr>
                        <td><strong>dementia_stage</strong></td>
                        <td>str</td>
                        <td>What stage of dementia or disease progression was studied? (e.g., 'early-stage AD', 'mild cognitive impairment', 'advanced AD', 'preclinical', null if no information)</td>
                    </tr>
                    <tr>
                        <td><strong>key_findings</strong></td>
                        <td>str</td>
                        <td>A concise, information-dense summary of the key findings related to selective vulnerability in the visual cortex. Focus on results that would help explain WHY certain populations are vulnerable while others are resistant.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div class="section">
            <h2>Extraction Schema (Debug)</h2>
            <pre><code>{
    "id": "extraction-schema-95",
    "schema": [
        {
            "name": "neuronal_population_type",
            "type": "str",
            "description": "The specific type of neuronal population, cell type, cortical layer, or visual cortex region being studied (e.g., 'layer 5 pyramidal neurons', 'parvalbumin-positive interneurons', 'V1 primary visual cortex', 'MT/V5 motion area', etc.)"
        },
        {
            "name": "vulnerability_status",
            "type": "str",
            "description": "Is this neuronal population vulnerable, resistant, or intermediate to amyloid-β and/or tau pathology? Be specific about which pathology if only one is mentioned."
        },
        {
            "name": "amyloid_beta_measurement",
            "type": "str",
            "description": "Quantitative or qualitative measurements of amyloid-β plaque burden, density, or accumulation in this neuronal population (include units and numerical values if available, null if no information)"
        },
        {
            "name": "tau_measurement",
            "type": "str",
            "description": "Quantitative or qualitative measurements of tau tangle burden, density, or accumulation in this neuronal population (include units and numerical values if available, null if no information)"
        },
        {
            "name": "cellular_properties",
            "type": "str",
            "description": "Specific cellular or molecular properties of this neuronal population that are mentioned in relation to vulnerability or resistance (e.g., metabolic rate, calcium buffering capacity, connectivity patterns, gene expression profiles, protein levels, etc.)"
        },
        {
            "name": "proposed_mechanism",
            "type": "str",
            "description": "The proposed mechanism or explanation for why this neuronal population is vulnerable or resistant to pathology. Be detailed and specific."
        },
        {
            "name": "comparative_population",
            "type": "str",
            "description": "If the study compares this population to another population with different vulnerability, name the comparison population and briefly describe the key differences."
        },
        {
            "name": "species_and_model",
            "type": "str",
            "description": "What species and experimental model was used? (e.g., 'human post-mortem tissue', 'APP/PS1 mouse model', '3xTg-AD mice', etc.)"
        },
        {
            "name": "dementia_stage",
            "type": "str",
            "description": "What stage of dementia or disease progression was studied? (e.g., 'early-stage AD', 'mild cognitive impairment', 'advanced AD', 'preclinical', null if no information)"
        },
        {
            "name": "key_findings",
            "type": "str",
            "description": "A concise, information-dense summary of the key findings related to selective vulnerability in the visual cortex. Focus on results that would help explain WHY certain populations are vulnerable while others are resistant."
        }
    ],
    "extraction_query": "Extract any mentions of selective vulnerability or resistance of specific neuronal populations, cell types, layers, or regions within the visual cortex to amyloid-β (amyloid-beta) plaques and tau protein tangles in the context of dementia or Alzheimer's disease.",
    "supporting_theory_ids": [],
    "model_str": "claude-sonnet-4-5-20250929"
}</code></pre>
        </div>
    </div>
</body>
</html>